These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36341409)
1. Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin. Masso-Silva JA; Sakoulas G; Olay J; Groysberg V; Geriak M; Nizet V; Crotty Alexander LE; Meier A Front Immunol; 2022; 13():993720. PubMed ID: 36341409 [TBL] [Abstract][Full Text] [Related]
2. Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series and Review of the Literature. Masso-Silva JA; Moshensky A; Lam MTY; Odish MF; Patel A; Xu L; Hansen E; Trescott S; Nguyen C; Kim R; Perofsky K; Perera S; Ma L; Pham J; Rolfsen M; Olay J; Shin J; Dan JM; Abbott RK; Ramirez S; Alexander TH; Lin GY; Fuentes AL; Advani I; Gunge D; Pretorius V; Malhotra A; Sun X; Duran J; Hepokoski M; Crotty S; Coufal NG; Meier A; Crotty Alexander LE Clin Infect Dis; 2022 Feb; 74(3):479-489. PubMed ID: 33988226 [TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production. Semple JW; Kim M; Hou J; McVey M; Lee YJ; Tabuchi A; Kuebler WM; Chai ZW; Lazarus AH PLoS One; 2012; 7(2):e31357. PubMed ID: 22363629 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin-induced neutrophil apoptosis in the lung during murine endotoxemia. Aoyama-Ishikawa M; Seishu A; Kawakami S; Maeshige N; Miyoshi M; Ueda T; Usami M; Nakao A; Kotani J Surg Infect (Larchmt); 2014 Feb; 15(1):36-42. PubMed ID: 24116740 [TBL] [Abstract][Full Text] [Related]
5. The effect of Intravenous Immunoglobulin (IVIG) on \textit{ex vivo} activation of human leukocytes. Basyreva LY; Brodsky IB; Gusev AA; Zhapparova ON; Mikhalchik EV; Gusev SA; Shor DB; Dahan S; Blank M; Shoenfeld Y Hum Antibodies; 2016; 24(3-4):39-44. PubMed ID: 28128763 [TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders. Prezzo A; Cavaliere FM; Milito C; Bilotta C; Iacobini M; Quinti I Blood Transfus; 2019 Mar; 17(2):103-111. PubMed ID: 30036181 [TBL] [Abstract][Full Text] [Related]
7. High Circulating Levels of Neutrophil Extracellular Traps Parameters Predicting Poor Outcome in COVID-19. Kim S; Hong KH; Gu JY; In JW; Ahn MY; Kim HK Ann Clin Lab Sci; 2022 May; 52(3):374-381. PubMed ID: 35777794 [TBL] [Abstract][Full Text] [Related]
8. Enhanced formation of neutrophil extracellular traps in Kawasaki disease. Yoshida Y; Takeshita S; Kawamura Y; Kanai T; Tsujita Y; Nonoyama S Pediatr Res; 2020 May; 87(6):998-1004. PubMed ID: 31935748 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828 [TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical immunoglobulins reduce neutrophil extracellular trap formation and ameliorate the development of MPO-ANCA-associated vasculitis. Uozumi R; Iguchi R; Masuda S; Nishibata Y; Nakazawa D; Tomaru U; Ishizu A Mod Rheumatol; 2020 May; 30(3):544-550. PubMed ID: 30932727 [No Abstract] [Full Text] [Related]
11. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study. Ali HS; Elshafei MS; Saad MO; Mitwally HA; Al Wraidat M; Aroos A; Shaikh N; Ananthegowda DC; Abdelaty MA; George S; Nashwan AJ; Mohamed AS; Khatib MY BMC Pulm Med; 2021 Nov; 21(1):354. PubMed ID: 34743710 [TBL] [Abstract][Full Text] [Related]
12. A targetable 'rogue' neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS. Herrera VLM; Walkey AJ; Nguyen MQ; Gromisch CM; Mosaddhegi JZ; Gromisch MS; Jundi B; Lukassen S; Carstensen S; Denis R; Belkina AC; Baron RM; Pinilla-Vera M; Mueller M; Kimberly WT; Goldstein JN; Lehmann I; Shih AR; Eils R; Levy BD; Ruiz-Opazo N Sci Rep; 2022 Apr; 12(1):5583. PubMed ID: 35379853 [TBL] [Abstract][Full Text] [Related]